Crocs Revealed The Silver Fox - A Nano-Silver Shoe

Today, CrocsRx(TM), the medical division of Crocs, Inc., revealed a new, sleeker addition to its therapeutic collection, the Silver Fox. Combining Crocs' legendary comfort with fashion-forward sensibility, this classic mary jane style includes a 1½ inch heel. The new Silver Fox shoe, will be on display for doctors and medical professionals to view, along with the entire CrocsRx(TM) collection at Crocs booth #211 at The 2008 Western Podiatric Medical Congress show, June 19-22 in Anaheim, California.

Carrying both the distinguished United States ergonomics endorsement, as well as approval from the American Podiatric Medical Association (APMA), the Silver Fox is the first shoe in the collection to be designed specifically for a woman’s foot. Complete with Croslite AG+(TM) material, a revolutionary material created from nano-Silver ceramic crystals, the shoe is anti-bacterial and anti-fungal, thus killing harmful strains of bacteria and fungi which are routinely the source of foot infections. Additionally, the shock absorbing sole relieves stress on feet, knees, hips, and the lower back making it a sensible footwear choice for heel pain, arch pain and ultra sensitive feet. Offered in three sophisticated color combinations including bronze/brown, cotton candy/burgundy, and classic black/black, the Silver Fox (MSRP: $49.99) is available in women’s sizes 4-10.

“The addition of the Silver Fox is a prime example of our efforts to continually provide new and innovative footwear styles that incorporate our medical foot bed and our cutting edge CrosliteAg+(TM) material,” stated Eddie Scott, director of the CrocsRx(TM) Collection. “Just as our core collection continues to evolve, we’ve broadened our styles to appeal to a more diverse audience within the medical market.”

To learn more about CrocsRx(TM) footwear, or join the more than 3,000 doctors that either recommend shoes from the CrocsRx(TM) line to their patients or distribute CrocsRx(TM) models directly through their offices, visit

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback